Medibank Private (MPL.AX) Aandeel Koers
Medibank Private Koers
De omzet is de afgelopen 19 jaar met 5,8% per jaar gegroeid tot 9,33 Miljard AUD. De winst per aandeel is de afgelopen 13 jaar met 8,1% per jaar gegroeid. De nettowinstmarge van Medibank Private ligt op 6,8% en is ten opzichte van 5,6% enkele jaren eerder gestegen. Medibank Private biedt momenteel een dividendrendement van circa 2,28%. De uitkeringsratio ligt rond 129% van de winst. Het dividend is de afgelopen 11 jaar met 4,2% per jaar gegroeid. Analisten hanteren een mediaan koersdoel van 5,00 AUD — dat impliceert 4,1% onder de huidige koers. Van de 14 analisten geven 5 het aandeel een koopadvies — per saldo een Houden-consensus.
Medibank Private aandeelkoers
Deze data ophalen via de Eulerpool API
100.000 requests/maand gratis · geen creditcard
Medibank Private bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over Medibank Private
Medibank Private Ltd operates as a leading private health insurance provider in Australia. The company's business model revolves around offering health insurance products and services to a wide range of individuals and families. Medibank Private aims to ensure accessibility, affordability, and quality healthcare for its customers. The company's model focuses on providing comprehensive coverage, including hospital treatment, specialist consultations, and ancillary services. By leveraging its extensive network of healthcare providers and utilizing advanced technological solutions, Medibank Private delivers value-based and customer-centric healthcare solutions. With a strong emphasis on innovation and customer satisfaction, Medibank Private continues to serve as a reliable and trusted health insurance partner.
Medibank Private Ltd is primarily active in the healthcare industry.
The main competitors of Medibank Private Ltd in the market include Bupa Australia, HCF, NIB Holdings Ltd, and HBF Health Limited.
Medibank Private Ltd is an Australian private health insurance company. It was established in 1976 as a government-owned entity to provide affordable health coverage to Australians. Initially, it operated as a not-for-profit organization until it was privatized in 2014 and listed on the Australian Securities Exchange (ASX). Since then, Medibank has evolved into a leading health insurer, offering a wide range of health insurance products and services to individuals, families, and businesses across Australia. With a strong focus on customer satisfaction and innovative healthcare solutions, Medibank Private Ltd continues to play a vital role in ensuring the well-being of millions of Australians.
Medibank Private Ltd, Australia's leading health insurer, has achieved several significant milestones throughout its history. One of the key achievements was its successful initial public offering (IPO) in 2014, marking its transition from a government-owned entity to a publicly listed company. Since then, Medibank has consistently delivered strong financial performance, demonstrating its commitment to shareholder value. The company has also expanded its services by introducing innovative healthcare programs and partnerships, aimed at improving the health and well-being of its members. Medibank's focus on customer satisfaction and high-quality healthcare has enabled it to become a trusted name in the industry, further reinforcing its position as a market leader.
Medibank Private Ltd is primarily present in Australia. This leading private health insurance provider operates predominantly in its home country, catering to a wide customer base. With its headquarters located in Melbourne, Medibank Private Ltd offers a range of health insurance services and products to individuals, families, and businesses across Australia.
Medibank Private Ltd represents a commitment to delivering high-quality healthcare services to its customers. The company values customer satisfaction and aims to provide accessible and affordable healthcare for all Australians. Medibank Private Ltd places importance on innovation, investing in new technologies and approaches to improve healthcare outcomes. With a focus on corporate responsibility, the company aims to make a positive impact on the health and wellbeing of individuals and communities. Medibank Private Ltd strives to be a trusted and customer-centric healthcare provider, ensuring the utmost care and support for its customers' health needs.
Analisten hanteren momenteel een gemiddeld koersdoel van 5,22 AUD voor het aandeel Medibank Private (mediaan: 5,00 AUD), oftewel +1,3 % ten opzichte van de laatste koers. De consensus is gebaseerd op 14 analistenratings.
14 analisten beoordelen het aandeel Medibank Private momenteel: 5 adviseren kopen, 9 houden en 0 verkopen.
Omgezet tegen de huidige wisselkoers noteert het aandeel Medibank Private op 3,21 EUR (5,21 AUD).
Het aandeel Medibank Private (MPL.AX) is genoteerd aan 5 beurzen, waaronder: SIX (Zürich) (MPV.SW), ASX (MPL.AX), Frankfurt (MPV.F), München (MPV.MU), Düsseldorf (MPV.DU).
Medibank Private Ltd is a leading Australian health insurance company that provides its customers with high-quality health solutions and medical services. The company operates in four main areas: health insurance, health services, private hospitals, and life insurance. It offers a wide range of health insurance products and services, including individual and family plans, group plans for businesses, and a variety of health services such as home visits, telemedicine, and emergency services. The private hospital division provides access to top-notch facilities and medical services. The company also offers life insurance products and services, including life insurance, income protection insurance, and accident insurance. Medibank Private aims to improve the customer experience through innovative technologies and digital services, offering tools and applications to manage and improve health and lifestyle. Overall, Medibank Private has a strong business model focused on providing high-quality health solutions and medical services, with a strong market position and a commitment to expanding its product and service offerings to meet the changing needs of its customers.
De omzet van Medibank Private bedraagt 9,33 Miljard AUD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.
De winst van Medibank Private bedraagt 638,70 Miljoen AUD. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.
De koers-winstverhouding (P/E) van Medibank Private bedraagt momenteel 22,46. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het Medibank Private-aandeel in te schatten.
De koers-omzetverhouding (P/S) van Medibank Private bedraagt momenteel 1,54. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het Medibank Private-aandeel.
De Eulerpool Kwaliteitsscore voor Medibank Private is 7/10.
De ISIN van Medibank Private is AU000000MPL3. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
De WKN van Medibank Private is A12D1W. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.
Het tickersymbool van Medibank Private is MPL.AX. Onder dit beurstickersymbool wordt het Medibank Private-aandeel op de beurs verhandeld.
Medibank Private aandeel
Medibank Private Peer Group
Medibank Private Ticker
Medibank Private FIGI
Alle fundamentals en diepgaande analyse van Medibank Private
Onze aandelenanalyse van het Medibank Private-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van Medibank Private. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: